Children's Hospital Research Institute of Manitoba
10
3
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
20%
2 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Role: collaborator
Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone Study
Role: collaborator
Advancing Family Wellbeing Through a Massive Open Online Intervention: The LightBEAM Program
Role: collaborator
Building Emotional Awareness and Mental Health (BEAM) 2024-2027
Role: collaborator
Pediatric Readiness Intervention in Manitoba
Role: collaborator
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
Role: collaborator
Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity
Role: collaborator
A Clinical Trial of Silver Diamine Fluoride to Arrest Early Childhood Caries in Young Children
Role: collaborator
Single-Session Psychotherapy for Young Kids Through Patient Engagement Techniques
Role: collaborator
The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol
Role: collaborator
All 10 trials loaded